T-cell Lymphoma Forum

San Francisco, CA USA
T-cell Lymphoma Forum 
San Francisco

Schedule of Presentations:

Thursday, January 23, 2014
06:00:00 T-cell Lymphoma Forum Francine Foss, Owen A. O'Connor, Kensei Tobinai, Ranjana H. Advani, Wei Ai, Paul M. Barr, Susan E. Bates, Govind Bhagat, Achiléa L Bittencourt, Serge Marchand, Wing C Chan, Bruce D. Cheson, Shigeru Chiba, Francesco A. d'Amore, Madeleine Duvic, Adolfo Ferrando, Peter HR Green, Joan Guitart, Helen E. Heslop, Steven M. Horwitz, HuiQiang Huang, Arnaud Jaccard, Elaine S. Jaffe, Yok-Lam Kwong, Pier Paolo Piccaluga, Lauren C. Pinter-Brown, Barbara Pro, Yutaka Shimazu, Andrei R. Shustov, Maarten H Vermeer, Thomas A Waldmann, Dennis D. Weisenburger, Motoko Yamaguchi, Noriaki Yoshida, Pier Luigi Zinzani
14:00:00 Welcome and introduction Francine Foss
14:10:00 Introduction of keynote presenter Thomas Waldmann
14:15:00 Keynote address: Historical trek through T-cell lymphoma Elizabeth M Jaffee
15:00:00 Global distribution of celiac disease and its association with EATL
15:15:00 T-cell lymphoma in Argentina
15:30:00 Recent achievements in NK/T lymphoma in China
15:45:00 Panel Discussion
16:05:00 Break
16:30:00 Using a molecular classifier in diagnosis and prognosis
16:45:00 MicroRNA expression profiling identifies molecular signatures of ALCL
17:00:00 γδ T-cell phenotype in cutaneous lymphomas
17:15:00 Transcriptome sequencing in sezary syndrome
17:30:00 The genomic landscape of PTCL
17:45:00 Panel Discussion
19:00:00 Welcome Dinner
Friday, January 24, 2014
07:00:00 CME Breakfast Symposium: Advancing the Care of Patients with Peripheral T-Cell Lymphoma
08:30:00 Day 2 opening remarks:
08:35:00 Deciphering the pathogenesis of EATL [link between celiac spru & EATL]
08:50:00 Multi-step tumorigenesis in peripheral T-cell lymphoma
09:05:00 New entities in T-cell lymphoma: Variance or new disease? 1) Primary PTCL, NOS of the thyroid
09:20:00 2) Indolent PTCL
09:35:00 Detection of CD30 in PTCLs
09:50:00 Panel Discussion
10:15:00 Break
10:30:00 Immunotherapy targeting cancer/testis antigen in ATL
10:45:00 Targeting IL-2/IL-15R in T-LGL
11:00:00 A novel mouse model for sezary syndrome using RAG2(-/-) gammac(- /-) mice
11:15:00 The spectrum of epigenetic lesions in PTCL: New strategies for targeting them
11:30:00 Panel Discussion
12:00:00 Lunch Symposium
14:00:00 Management of localized and advanced NK/TCL: The Japanese perspective
14:15:00 Management of advanced NK/TCL: The Hong Kong perspective
14:30:00 Management of NK-/T-cell lymphoma: The French perspective
14:45:00 Panel Discussion
15:00:00 Break
15:15:00 Targeting the epigenome in T-cell lymphoma: Moving beyond HDAC inhibitors
15:30:00 Single-agent therapy: The old and the new
15:45:00 Autologous transplant: Is there a role in the relapsed setting?
16:00:00 Making the case for allogeneic stem cell transplant before autologous: Is it ever appropriate?
16:15:00 Updates on allogeneic stem cell transplant in CTCL
16:30:00 Is there a role for maintenance therapy in relapsed disease?
16:45:00 Panel Discussion
17:15:00 Poster presentations
18:30:00 Poster Walk Reception
Saturday, January 25, 2014
07:00:00 Continental Breakfast
08:00:00 Day 3 opening remarks:
08:05:00 Management of T-cell lymphoma: What the registries tell us
08:20:00 Ongoing randomized trials in TCL: Small molecules
08:35:00 Updates of clinical trials targeting CCR4
08:50:00 Identifying the control arm in randomized T-cell studies: Opportunities to expedite accrual in upfront studies of TCL
09:05:00 Trial updates: Aurora kinase inhibitors
09:20:00 Drug profile screening for pathway-directed therapy
09:35:00 Priming T-cells vs. CD30
10:10:00 Panel Discussion
10:30:00 Break
10:45:00 Introduction
10:50:00 Considerations for future WHO modification in T-cell lymphoma classification
11:05:00 PTCL consortium
11:20:00 Geographic diversity of ATLL in Brazil
11:35:00 Distribution and frequency of PTCL in South India
11:50:00 Discussion
12:30:00 Adjourn
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.